Shares of Citius Oncology, a lymphoma drug developer with a market capitalization of $110 million, jumped more than 18% on Monday, January 6, following the announcement that it had hired the investment bank Jefferies as a financial advisor to explore strategic alternatives. Details On Monday, Citius Oncology stock soared more…